Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
Seasoned governance expert and board leader brings extensive experience in strategic oversight, risk management, and corporate governance across multiple sectors
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
We are building the bridge between complex molecular data and everyday clinical decisions
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
The newly commissioned facility strengthens the ’company’s capabilities in the development and manufacturing of generic and complex sterile injectable products
Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy
Community healthcare initiatives reach a milestone year, with services spanning 90 districts, 22 states, and over 70 lakh cumulative beneficiaries since 2006
Donor families honoured as Apollo highlights over 27,500 transplants performed and calls for greater public participation in organ donation
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
